Telix Pharmaceuticals Limited (TLX)

Telix Pharmaceuticals will go public soon, but the exact IPO date is still unknown.
IPO Price
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 4.05B
Revenue (ttm) 386.76M
Net Income (ttm) 21.26M
Shares Out 341.06M
EPS (ttm) 0.06
PE Ratio 190.42
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About TLX

Telix Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. Our mission is to be the global leader in radiopharmaceuticals by combining therapeutic and diagnostic modalities for the benefit of patients, an innovative precision medicine concept generally referred to as “theranostics”. We have an extensive pipeline of theranostic radiopharmaceutical product candidates with a focus in urologic oncology (prostate and kidney), neuro-oncolog... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 415
Stock Exchange NASDAQ
Ticker Symbol TLX
Full Company Profile

Financial Performance

Financial numbers in AUD Financial Statements


Telix Announces Launch of Proposed Initial Public Offering in the United States

Telix Pharmaceuticals Limited today announces the launch of its initial public offering in the United States of 17,000,000 American Depositary...

9 days ago - GLOBE NEWSWIRE

Australian radiopharmaceutical biotech Telix Pharmaceuticals files for a $100 million US IPO

Telix Pharmaceuticals, a commercial-stage Australian biotech developing therapeutic and diagnostic radiopharmaceuticals, filed on Friday with the SEC to raise up to $100 million in an initial public o...

4 weeks ago - Renaissance Capital

Telix Files Registration Statement for Proposed Initial Public Offering in the United States

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has filed a...

4 weeks ago - GLOBE NEWSWIRE

Telix Pharmaceuticals IPO Registration Document (F-1)

Telix Pharmaceuticals has filed to go public with an IPO on the NASDAQ.

4 weeks ago - SEC